← Back to Search

Behavioural Intervention

Arm I (Chaplain delivered compassion meditation) for Lymphoma

N/A
Recruiting
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 8 months
Awards & highlights

Study Summary

This trial tests if chaplains can help patients undergoing stem cell transplantation by teaching them compassion meditation. This meditation program aims to improve emotional well-being and strengthen compassion for oneself and others. The goal is

Who is the study for?
This trial is for patients with Lymphoma or Multiple Myeloma who are undergoing stem cell transplantation. It aims to see if chaplain-led compassion meditation can help improve their spiritual care during treatment.Check my eligibility
What is being tested?
The study is testing a program where hospital chaplains deliver compassion meditation to patients. The goal is to see if this improves emotional and spiritual well-being, patient outcomes, and satisfaction with care.See study design
What are the potential side effects?
Since the intervention involves meditation and spiritual therapy rather than medication, no traditional medical side effects are expected. However, individual experiences may vary.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility - patient enrollment and treatment-specific retention rates
Secondary outcome measures
Acceptability - Chaplain Satisfaction Survey
Functional Assessment of Cancer Therapy-Bone Marrow Transplant [FACT-BMT]
Patient Characteristics Affecting Acceptability - Chaplain Satisfaction Survey

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (Chaplain delivered compassion meditation)Experimental Treatment1 Intervention
Patients receive chaplain led compassionate centered spiritual health sessions over 30 minutes, twice per week for up to 2 weeks.
Group II: Arm II (Traditional chaplain consultation)Active Control1 Intervention
Patients receive a traditional chaplain consultation and care upon request, per standard of care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spiritual Therapy
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,640 Previous Clinical Trials
2,560,646 Total Patients Enrolled
20 Trials studying Lymphoma
20,710 Patients Enrolled for Lymphoma
National Cancer Institute (NCI)NIH
13,671 Previous Clinical Trials
40,926,719 Total Patients Enrolled
1,383 Trials studying Lymphoma
382,351 Patients Enrolled for Lymphoma
National Center for Complementary and Integrative Health (NCCIH)NIH
833 Previous Clinical Trials
669,403 Total Patients Enrolled
3 Trials studying Lymphoma
107 Patients Enrolled for Lymphoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there ongoing efforts to actively seek participants for this research study?

"The information available on clinicaltrials.gov confirms that this research project is presently in the recruitment phase. The trial was first listed on 10/18/2023 and last revised on 3/18/2024."

Answered by AI

What is the upper limit for the total number of individuals involved in this research investigation?

"Indeed, data provided on clinicaltrials.gov confirms the ongoing recruitment of participants for this trial. The trial was first listed on October 18th, 2023 and had its most recent update on March 18th, 2024. It aims to enroll a total of 54 patients from one specified location."

Answered by AI
~0 spots leftby May 2024